Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
CoJax Oil & Gas Corp reported a net income of $2,895 for the quarter ended September 30, 2026, a significant improvement from a net loss of $157,705 in the prior year period. Despite achieving profitability in the last two quarters, management expressed substantial doubt about the company's ability to continue as a going concern due to insufficient profits to support business expansion.
Enhanced Group Inc. is an emerging growth company focused on enhancement-based athletic competition and the Live Enhanced platform. The filing highlights significant risks including a limited operating history, minimal revenues, and a need for additional capital to continue as a going concern following its recent business combination.
Cingulate reported Q3 2026 financial results, highlighting a cash position of $23.2 million and progress on its CTx-1301 NDA resubmission. The company has substantially completed manufacturing work to address FDA CMC requests and expects to resubmit the NDA between December 2026 and January 2027. Additionally, the company added Maxim Group LLC as a sales agent to its existing $100 million ATM equity offering program.
Term
Q3 2026
“With the manufacturing work substantially complete, we are now finalizing the data and documentation needed to resubmit the NDA for CTx-1301, and we expect to do so by January 2027, potentially sooner.”
Shane J. Schaffer, Chairman and CEO
“Importantly, the FDA’s Complete Response Letter did not raise any concerns about the clinical safety or efficacy of CTx-1301. We thank our shareholders for their patience and continued support as we work to bring this treatment to patients with ADHD.”
Amaze Holdings, Inc. reported a significant net loss of $32.3 million for the nine months ended September 30, 2026, primarily driven by a $17.7 million impairment of intangible assets. Revenues declined sharply to $0.47 million in the third quarter compared to $1.25 million in the prior year period, while the company's stockholders' equity shifted from a surplus of $9.8 million to a deficit of $8.2 million.
Edgewell Personal Care Co. is focused on its 'Sustainable Care' strategy, targeting reductions in petroleum-based plastics, greenhouse gas emissions, and waste diversion. The company reported approximately 6,500 employees as of September 30, 2026, and continues to manage significant regulatory compliance obligations under the FDA, CPSC, TSCA, and REACH frameworks.
Pasithea Therapeutics Corp. reported a net loss of $14.7 million for the nine months ended September 30, 2026, driven by a significant increase in research and development expenses to $11.1 million. The company maintained a cash position of $41.2 million as of the end of the period, down from $55.2 million at the start of the year.
For the nine months ended September 30, 2026, Health In Tech, Inc. reported total revenues of $23.4 million, a decrease from $25.8 million in the prior year period. The company experienced a significant shift in its financial position, moving from a retained earnings balance of $5.2 million at the end of 2025 to an accumulated deficit of $5.9 million as of September 30, 2026.
Nuo Therapeutics reported a significant revenue increase to $4.9 million for the nine months ended September 30, 2026, compared to $2.2 million in the prior year, driven by product sales and distribution fees. Despite the growth, the company remains in a stockholders' deficit and continues to rely on debt financing, including $1.175 million in net proceeds from notes payable issued during 2026.
Nuvve Holding Corp. reported a total revenue of $1.09 million for the quarter ended September 30, 2026, down from $1.60 million in the prior year period. The company experienced a net loss of $4.69 million for the quarter, contributing to a total stockholders' deficit of $13.42 million as of September 30, 2026.
Cheetah Net Supply Chain Service Financial Results
Cheetah Net Supply Chain Service reported Q3 2026 revenue of $3.56 million, an 883% increase year-over-year driven by its international trading business acquisition. Despite the revenue growth, the company reported a net loss from continuing operations of $2.55 million, primarily due to a $2.78 million non-cash loss from the change in fair value of acquisition-related contingent consideration.
Term
Q3 2026
“The third quarter of 2026 marked an important step forward in the execution of our business diversification strategy. Following the acquisition of Super International Trading Limited in May, our international trading business demonstrated encouraging momentum, generating approximately $3.56 million in revenue during the quarter.”
Tony Liu, Cheetah’s Chairman and CEO
“Looking ahead, we remain committed to disciplined capital allocation, prudent financial management, and the pursuit of strategic opportunities that complement our existing capabilities.”
CaliberCos Inc. reported a net loss of $18.0 million for the nine months ended September 30, 2026, compared to a $15.0 million loss in the prior year period. Total assets increased significantly to $178.9 million from $135.4 million at year-end 2025, primarily driven by the consolidation of new investment funds and real estate assets.
Cumberland Pharmaceuticals reported a significant net income of $77.8 million for the quarter ended September 30, 2026, primarily driven by an $81.1 million gain from the disposal of discontinued operations. Total revenue from continuing operations increased to $2.2 million, while the company declared a substantial cash dividend of $22.5 million during the period.
Where Food Comes From reported Q3 2026 total revenue of $7.3M, up 4% year-over-year, driven by 6% growth in its core verification and certification business. Operating income grew 68% to $1.0M as gross margins expanded to 42.1% due to cost-reduction initiatives and service bundling. The company also returned $268,000 to shareholders through stock buybacks during the quarter.
Term
Q3 2026
“We are pleased to report strong third quarter financial results highlighted by 6% growth in our core verification and certification business that is benefitting from resurgent demand for beef-related services and growing momentum in other service offerings.”
John Saunders, Chairman and CEO
“Our profit metrics also showed continued strength with gross margins rising by 380 basis points to 42.1% and operating income growing 68% to $1.0 million from $600,000 a year ago – both reflecting the positive impact of our ongoing cost down initiatives in conjunction with accelerating revenue.”
Research Alliance Corp IV reported a net income of $379,042 for the quarter ended September 30, 2026, primarily driven by $534,815 in interest earned on marketable securities held in the Trust Account. As a shell company, its activities are focused on identifying a target for a business combination, with $75,534,815 currently held in trust for its Class A ordinary shares.
CIM Opportunity Zone Fund, L.P. reported a net loss of $44.8 million for the nine months ended September 30, 2026, compared to a net income of $110.8 million in the prior year period. The decline was primarily driven by the absence of a $117.4 million realized gain on a lease investment recorded in 2025 and increased operating and interest expenses.
DataMeds AI, Inc. (formerly Wellgistics Health, Inc.) reported a net income of $10.5 million for the quarter ended September 30, 2026, primarily driven by a $19.1 million gain on debt extinguishment. However, the company experienced a significant decline in nine-month revenues from $21.7 million in 2025 to $6.0 million in 2026, resulting in a year-to-date net loss of $15.6 million.
GRI Bio, Inc. reported a net loss of $5.15 million for the nine months ended September 30, 2026, a significant reduction from the $9.30 million loss in the prior year period, primarily due to lower research and development expenses. The company strengthened its liquidity through an ATM offering, ending the period with $9.47 million in cash and cash equivalents. GRI Bio remains a clinical-stage biopharmaceutical company with an accumulated deficit of $56.84 million and no significant revenue.
Processa Pharmaceuticals reported a significant net loss of $189.8 million for the nine months ended September 30, 2026, primarily driven by a $178.0 million charge for acquired in-process research and development following the acquisition of Vidya Therapeutics. The company significantly strengthened its liquidity position during the period, ending with $180.2 million in cash and cash equivalents following a $200.0 million private placement financing.
Valor Energy Inc reported a significant net loss of $40.8 million for the six months ended September 30, 2026, primarily driven by a $34.1 million non-cash charge for the excess of warrant fair value over offering proceeds. Despite the loss, the company strengthened its cash position to $12.5 million following a $10.2 million net inflow from a Units Private Placement.
Astrotech reported a net loss of $2.9 million for the quarter ended September 30, 2026, compared to a $3.5 million loss in the prior year. Revenue decreased slightly to $274 thousand, while the company maintained a cash position of $5.6 million following an 'at-the-market' share issuance that raised $467 thousand.
Kairos Pharma, Ltd. reported a net loss of $5.03 million for the nine months ended September 30, 2026, compared to a $4.08 million loss in the prior year period. The company remains in the development stage with no revenue, and its cash position decreased to $3.13 million as of September 30, 2026, from $4.49 million at year-end 2025.
Cerenome, Inc. reported a net loss of $24.6 million for the nine months ended September 30, 2026, compared to a $16.7 million loss in the prior year period. While the company introduced diagnostic revenue of $0.7 million, total revenue decreased due to lower grant revenue, and operating expenses nearly doubled to $25.8 million.
Beasley Broadcast Group reported third quarter 2026 net revenue of $42.8 million, a 16.1% decrease year-over-year driven by weakness in national and local agency advertising. The company reported a net loss of $12.1 million for the quarter but highlighted improved digital operating margins of 32% and the completion of asset sales generating over $10 million in proceeds subsequent to quarter-end.
Health In Tech reported Q3 2026 revenue of $6.6 million and a net loss of $7.1 million, which included a $5.3 million provision for credit losses. The company highlighted a 15.9% year-over-year growth in distribution partners and a revenue pipeline of $156.4 million as of late October.
Term
Q3 2026
“It is a privilege to lead Health In Tech into its next chapter, and I want to thank Tim Johnson, our founder and Executive Chairman, and the Board for their confidence. Throughout my career, I have focused on scaling businesses, developing growth strategies, and leveraging capital markets to support long-term value creation. I have substantial operational experience scaling new products from incubation to meaningful commercial scale, building”
Sanjay Shrestha, Chief Executive Officer of Health In Tech
Cheetah Net Supply Chain Service Inc. reported a significant increase in revenue to $4.52 million for the nine months ended September 30, 2026, compared to $1.20 million in the prior year. Despite this growth, the company realized a net loss of $3.09 million, driven by high operating expenses and a $2.78 million loss related to the change in fair value of an acquisition-related contingent consideration asset.
Healthcare Triangle, Inc. reported a significant revenue increase to $28.2 million for the nine months ended September 30, 2026, compared to $10.8 million in the prior year, driven by business expansion. However, the company continues to operate at a loss, with a net loss from operations of $9.7 million for the period and a total asset base that grew to $72.7 million following substantial increases in intangible assets.
Fly-E Group, Inc. reported a significant decline in revenue to $5.34 million for the six months ended September 30, 2026, compared to $9.24 million in the prior year period. The company's net loss widened to $5.68 million for the same period, driven by decreased gross profit and high general and administrative expenses, raising concerns about its ability to continue as a going concern.
Presidio Property Trust reported a decrease in total revenue to $10.57 million for the nine months ended September 30, 2026, compared to $12.70 million in the prior year period. The company experienced a significant reduction in total assets from $122.1 million at year-end 2025 to $86.3 million, primarily driven by a decrease in real estate assets held for investment.
Scientific Industries reported a net loss of $2.35 million for the nine months ended September 30, 2026, compared to a net income of $0.69 million in the prior year period. While revenues increased to $4.05 million from $3.43 million, the prior year's profitability was primarily driven by a larger gain on the disposition of discontinued operations.
Mobiquity Technologies reported a significant revenue increase to $334,896 for the nine months ended September 30, 2026, compared to $160,795 in the prior year. However, net loss widened to $8.6 million due to higher general and administrative expenses, resulting in a total stockholders' deficit of $221,189.